Verve Therapeutics, Inc.

Clinical-stage genetic medicine company focused on developing therapies for cardiovascular diseases. Verve Therapeutics leverages human genetic analysis, gene editing, messenger RNA-based therapies, and lipid nanoparticle delivery to create innovative treatments. The company's primary target demographic includes patients suffering from cardiovascular conditions seeking advanced genetic-based therapeutic options.